Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability-Reference-Cited by-同舟云学术

Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability

Published:2017-08-29 Issue:6 Volume:56 Page:1077-1084
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Berry James D.¹²,Paganoni Sabrina¹²,Atassi Nazem¹²,Macklin Eric A.¹²,Goyal Namita³,Rivner Michael⁴,Simpson Ericka⁵,Appel Stanley⁵,Grasso Daniela L.¹,Mejia Nicte I.¹,Mateen Farrah¹,Gill Alan⁶,Vieira Fernando⁶,Tassinari Valerie⁶,Perrin Steven⁶

Affiliation:

1. Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School; 165 Cambridge Street, Suite 600, Boston Massachusetts 02114 USA

2. Department of Neurology; Harvard Medical School; Boston Massachusetts USA

3. Department of Neurology; University of California; Irvine, Orange California USA

4. Department of Neurology; Augusta University Medical Center; Augusta Georgia USA

5. Department of Neurology; Methodist Hospital; Houston Texas USA

6. ALS Therapy Development Institute; Cambridge Massachusetts USA

Funder

ALS Therapy Development Institute

Novartis

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Reference31 articles.

1. Amyotrophic lateral sclerosis;Wijesekera;Orphanet J Rare Dis,2009

2. Long-term survival in amyotrophic lateral sclerosis: a population-based study;Pupillo;Ann Neurol,2014

3. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group;Bensimon;N Engl J Med,1994

4. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND);Miller;Cochrane Database Syst Rev,2012

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Drugs Strategies for Treatment of Rare Neurodegenerative Diseases;Rare Neurodegenerative Disorders - New Insights [Working Title];2024-05-24

2. Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications;Current Opinion in Neurology;2024-05-22

3. Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies;Cells;2024-03-30

4. New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases;International Journal of Molecular Sciences;2024-02-26

5. The role of sphingosine-1-phosphate in autophagy and related disorders;Cell Death Discovery;2023-10-18